Works matching IS 02724391 AND DT 2004 AND VI 62 AND IP 3
1
- Drug Development Research, 2004, v. 62, n. 3, p. 172, doi. 10.1002/ddr.10380
- Luis Augusto Rohde;
- Cristian Zeni;
- Guilherme Polanczyk;
- Mara H. Hutz
- Article
2
- Drug Development Research, 2004, v. 62, n. 3, p. 254, doi. 10.1002/ddr.10362
- Suxing Liu;
- W. Robert Bishop;
- Bimal Dasmahapatra;
- Yaolin Wang
- Article
3
- Drug Development Research, 2004, v. 62, n. 3, p. 273, doi. 10.1002/ddr.10364
- Charles G. Mullighan;
- Peter G. Bardy
- Article
4
- Drug Development Research, 2004, v. 62, n. 3, p. 233, doi. 10.1002/ddr.10361
- Nicola F. Smith;
- William D. Figg;
- Alex Sparreboom
- Article
5
- Drug Development Research, 2004, v. 62, n. 3, p. 200, doi. 10.1002/ddr.10357
- Chee‐Eng Tan;
- E. Shyong Tai
- Article
6
- Drug Development Research, 2004, v. 62, n. 3, p. 161, doi. 10.1002/ddr.10379
- Prabha Ranganathan;
- Seth Eisen
- Article
7
- Drug Development Research, 2004, v. 62, n. 3, p. 191, doi. 10.1002/ddr.10356
- Donna K. Arnett;
- Steven A. Claas
- Article
8
- Drug Development Research, 2004, v. 62, n. 3, p. 221, doi. 10.1002/ddr.10360
- José I. Lao;
- Katrin Beyer;
- Aurelio Ariza
- Article
9
- Drug Development Research, 2004, v. 62, n. 3, p. 213, doi. 10.1002/ddr.10359
- Article
10
- Drug Development Research, 2004, v. 62, n. 3, p. 207, doi. 10.1002/ddr.10358
- Article
11
- Drug Development Research, 2004, v. 62, n. 3, p. 180, doi. 10.1002/ddr.10355
- John F. Carlquist;
- Jeffrey L. Anderson
- Article